AI-focused Digital Healthcare Collaborative Ecosystem
AIRA Matrix, the premier provider of Artificial Intelligence (AI) products and services in Digital Pathology has been selected in the 3rd cohort of the GE Healthcare India Edison™ Accelerator Program.
The GE Healthcare India Edison™ Accelerator is a collaborative ecosystem focused on tackling the toughest healthcare challenges and working towards the paradigm of “Precision Health”.
AIRA Matrix provides digital pathology solutions that enable medical professionals to make faster, concrete decisions and will leverage the Edison™ platform and GE Healthcare’s expertise to deliver Deep Learning solutions that address current accuracy and objectivity shortcomings in Prostate Carcinoma.
“The focal point of our collaboration will be on diagnostic, prognostic, and predictive solutions for prostate cancer, supported by the GE Edison™ platform. We intend to deploy innovative AI products with the goal of full-scale implementation in the long run.
We share a common goal with GE Healthcare to achieve cost-effective diagnostics, enhance patient experiences, augment healthcare workflows, and realize high throughput processes across the care continuum”” said Chath Kondragunta, CEO AIRA Matrix.
To know more, visit http://www.airamatrix.com/. If you are interested in collaborating, do connect with us at info@airamatrix.com.
About AIRA Matrix:
AIRA Matrix provides artificial intelligence based solutions for Life Sciences applications. Our solutions improve efficiency, diagnostic accuracy, and turnaround times in pathology, microbiology and ophthalmology workflows across pharmaceutical and healthcare laboratories.
We leverage machine and deep learning techniques to develop diagnostic, prognostic, and predictive solutions. Our solutions provide cost benefits in the pharmaceutical domain, by speeding up pre-clinical drug development timelines, and by enhancing the efficiency of environmental monitoring required in manufacturing. In healthcare applications, our solutions improve treatment outcomes by aiding disease stratification and enabling management protocols tailored to individual patients.
Our clients and partners include leading hospitals, pharmaceutical companies, CROs, and research labs around the world.
Source: AIRA Matrix
